Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Adverse drug events (ADEs) and opportunistic infections (OIs) associated expenditures among 276 Chinese patients in their first year of ARV therapy

From: Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs

Categories No. of events (%) Average expenditures (US dollars)
   Medications Tests for diagnosis Other medical services Total
ADEs
   Hepatotoxicity 114 (41.3) $82 $12 $34 $127
   Allergic dermatitis 66 (23.9) $41 $5 $26 $72
   Gastrointestinal disorders 60 (21.7) $36 $6 $20 $62
   Anemia 29 (10.5) $43 $17 $34 $95
   Dizziness and tiredness 14 (5.1) $26 $1 $9 $36
   Peripheral neuritis 5 (1.8) $429 $11 $206 $645
   Others 12 (4.4) $16 $0 $3 $19
OIs
   Fungal Infection 17 (6.2) $88 $11 $59 $158
   Respiratory infection 65 (23.6) $52 $9 $24 $85
   Tuberculosis 7 (2.5) $128 $48 $70 $245
   Diarrhea 20 (7.3) $34 $4 $20 $58
   Herpes simplex virus and zoster infection 13 (4.7) $76 $5 $26 $107
   Cytomegalovirus infection 5 (1.8) $763 $96 $349 $1,208
   Others 11 (4.0) $101 $107 $200 $408